1. Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA, Guidance for Industry, United States Food and Drug Administration, New Hampshire (2021); https://www.fda.gov/media/87219/download.
2. Zhen Zhang, Bioanalysis of Endogenous Compounds in PK BE Studies in ANDAs – Bioanalysis (2020); https://www.fda.gov/drugs/news-events-human-drugs/
3. V. Adonin, D. Romodanovskii, and R. Niyazov, Vedomosti Nauchn. Tsentra Ekspert. Sredstv Med. Primen., No. 3, 3 – 7 (2015).
4. D. Romodanovskii, D. Goryachev, A. Solov'eva, et al., Vedomosti Nauchn. Tsentra Ekspert. Sredstv Med. Primen., 8(1), 6 – 10 (2018).
5. Product-Specific Draft Guidance on Progesterone, United States Food and Drug Administration; https://www.accessdata.fda.gov/drugsatfdadocs/psg/Progesterone_caps_19781_RC02-11.pdf.